Curis (CRIS) Enterprise Value (2010 - 2026)
Curis' (CRIS) quarterly Enterprise Value came in at -$4.6 million in Q2 2026, up 48.25% on a YoY basis from -$3.1 million in Q2 2025, and up 68.19% quarter-over-quarter from -$14.5 million in Q1 2026.
Analysis
Curis (CRIS) Enterprise Value (2010 - 2026) Analysis & Trends
Curis (CRIS) has reported Enterprise Value for 17 consecutive years, with -$4.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value rose 48.25% year-over-year to -$4.6 million; the trailing twelve-month figure through Jun 2026 stood at -$4.6 million (up 48.25% YoY), and the FY2025 full-year result was -$4.4 million, up 76.76% from the prior year.
- Enterprise Value improved to -$4.6 million in Q2 2026 per CRIS's latest filing, from -$14.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.4 million in Q4 2025 and bottomed at -$109.7 million in Q1 2022.
- Historically, Enterprise Value has averaged -$44.4 million across 5 years, with a median of -$31.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value declined 4.92% in 2022, then surged 76.76% in 2025.
- Over 5 years, Enterprise Value stood at -$83.0 million in 2022, then surged by 36.63% to -$52.6 million in 2023, then jumped by 63.8% to -$19.0 million in 2024, then soared by 76.76% to -$4.4 million in 2025, then retreated by 4.08% to -$4.6 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$4.6 million, -$14.5 million, and -$4.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Curis | 2.63 Mn | -2.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.60 Mn |
| Mar 31, 2026 | -14.47 Mn |
| Dec 31, 2025 | -4.42 Mn |
| Sep 30, 2025 | -7.99 Mn |
| Jun 30, 2025 | -8.90 Mn |
| Mar 31, 2025 | -19.39 Mn |
| Dec 31, 2024 | -19.03 Mn |
| Sep 30, 2024 | -19.25 Mn |
| Jun 30, 2024 | -26.32 Mn |
| Mar 31, 2024 | -37.52 Mn |
| Dec 31, 2023 | -52.58 Mn |
| Sep 30, 2023 | -66.56 Mn |
| Jun 30, 2023 | -59.36 Mn |
| Mar 31, 2023 | -68.88 Mn |
| Dec 31, 2022 | -82.97 Mn |
| Sep 30, 2022 | -95.32 Mn |
| Jun 30, 2022 | -102.68 Mn |
| Mar 31, 2022 | -109.75 Mn |
| Dec 31, 2021 | -94.07 Mn |
| Sep 30, 2021 | -93.04 Mn |